Concord Medical Co Ltd Statistics
Concord Medical Co Ltd (6518) Stock Statistics & Valuation Metrics
Total Valuation
Concord Medical Co Ltd has a market cap or net worth of TWD 1.00B. The enterprise value is ―.
- Market Cap
- TWD 1.00B
- Enterprise Value
- ―
Share Statistics
Concord Medical Co Ltd has 33,333,336 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 33,333,336
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Concord Medical Co Ltd’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 6.35%.
- Return on Equity (ROE)
- 0.09
- Return on Assets (ROA)
- 0.06
- Return on Invested Capital (ROIC)
- 6.35%
- Return on Capital Employed (ROCE)
- 0.08
- Revenue Per Employee
- 12.05M
- Profits Per Employee
- 849.15K
- Employee Count
- 80
- Asset Turnover
- 0.79
- Inventory Turnover
- 88.70
Valuation Ratios
The current PE Ratio of Concord Medical Co Ltd is 11.61. Concord Medical Co Ltd’s PEG ratio is 0.20.
- PE Ratio
- 11.61
- PS Ratio
- 0.96
- PB Ratio
- 1.38
- Price to FCF
- 7.45
- Price to Operating Cash Flow
- 7.33
- PEG Ratio
- 0.20
Income Statement
In the last 12 months, Concord Medical Co Ltd had revenue of 964.35M and earned 67.93M in profits. Earnings per share was 2.02.
- Revenue
- 964.35M
- Gross Profit
- 133.96M
- Operating Income
- 72.78M
- Pretax Income
- 82.83M
- Net Income
- 67.93M
- EBITDA
- 157.74M
- Earnings Per Share (EPS)
- 2.02
Cash Flow
In the last 12 months, operating cash flow was 136.13M and capital expenditures -2.62M, giving a free cash flow of 133.50M billion.
- Operating Cash Flow
- 136.13M
- Free Cash Flow
- 133.50M
- Free Cash Flow per Share
- 3.99
Dividends & Yields
Concord Medical Co Ltd pays an annual dividend of ―, resulting in a dividend yield of 5.00%
- Dividend Per Share
- ―
- Dividend Yield
- 5.00%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 13.42%
- Earnings Yield
- 8.67%
Stock Price Statistics
- Beta
- 0.30
- 52-Week Price Change
- 14.37%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 38.49
- Average Volume (3m)
- 7,789
Financial Position
Concord Medical Co Ltd as a current ratio of 1.78, with Debt / Equity ratio of 24.51%
- Current Ratio
- 1.78
- Quick Ratio
- 1.76
- Debt to Market Cap
- 0.06
- Net Debt to EBITDA
- 0.34
- Interest Coverage Ratio
- 18.69
Taxes
In the past 12 months, Concord Medical Co Ltd has paid 14.90M in taxes.
- Income Tax
- 14.90M
- Effective Tax Rate
- 0.18
Enterprise Valuation
Concord Medical Co Ltd EV to EBITDA ratio is 6.78, with an EV/FCF ratio of 7.66.
- EV to Sales
- 0.99
- EV to EBITDA
- 6.78
- EV to Free Cash Flow
- 7.66
- EV to Operating Cash Flow
- 7.52
Balance Sheet
Concord Medical Co Ltd has TWD 225.93M in cash and marketable securities with TWD 179.94M in debt, giving a net cash position of TWD 45.99M billion.
- Cash & Marketable Securities
- TWD 225.93M
- Total Debt
- TWD 179.94M
- Net Cash
- TWD 45.99M
- Net Cash Per Share
- TWD 1.38
- Tangible Book Value Per Share
- TWD 21.88
Margins
Gross margin is 14.19%, with operating margin of 6.64%, and net profit margin of 8.33%.
- Gross Margin
- 14.19%
- Operating Margin
- 6.64%
- Pretax Margin
- 9.73%
- Net Profit Margin
- 8.33%
- EBITDA Margin
- 14.52%
- EBIT Margin
- 6.64%
Analyst Forecast
The average price target for Concord Medical Co Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 14.71%
- EPS Growth Forecast
- 56.74%
